Published in J Orthop Res on August 01, 2008
The influence of collagen-glycosaminoglycan scaffold relative density and microstructural anisotropy on tenocyte bioactivity and transcriptomic stability. J Mech Behav Biomed Mater (2011) 1.00
Comparison between normal and loose fragment chondrocytes in proliferation and redifferentiation potential. Int Orthop (2012) 0.78
The influence of pore size and stiffness on tenocyte bioactivity and transcriptomic stability in collagen-GAG scaffolds. J Mech Behav Biomed Mater (2016) 0.75
Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med (1985) 8.45
Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med (1989) 6.37
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med (1989) 6.24
1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. N Engl J Med (1975) 5.48
Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med (1993) 5.39
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst (1996) 5.28
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol (1994) 4.50
The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer (1975) 4.12
The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol (1993) 4.09
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med (1985) 3.41
Randomized trial of brief family interventions for general populations: adolescent substance use outcomes 4 years following baseline. J Consult Clin Psychol (2001) 3.30
Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. J Clin Oncol (1990) 3.12
The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet (1981) 3.11
Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst (1988) 3.09
Direct and indirect latent-variable parenting outcomes of two universal family-focused preventive interventions: extending a public health-oriented research base. J Consult Clin Psychol (1998) 3.03
Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02. J Clin Oncol (1990) 2.89
Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet (1991) 2.70
Deadly relic of the Great War. Nature (1998) 2.41
Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer (1977) 2.16
Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer (1978) 2.10
Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). V. Significance of axillary nodal micro- and macrometastases. Cancer (1978) 2.08
Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience. J Clin Oncol (1989) 2.03
A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med (1989) 1.99
Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. J Natl Cancer Inst (1995) 1.94
Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer. J Clin Oncol (1983) 1.94
Lumpectomy for breast cancer: an update of the NSABP experience. National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst Monogr (1992) 1.84
Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. J Natl Cancer Inst (1988) 1.72
Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminants. Cancer (1993) 1.70
Engaging families in longitudinal preventive intervention research: discrete-time survival analysis of socioeconomic and social-emotional risk factors. J Consult Clin Psychol (1999) 1.66
Risk factors for fatal lateral condylar fracture of the third metacarpus/metatarsus in UK racing. Equine Vet J (2005) 1.57
The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings. Cancer (1980) 1.48
Modeling factors influencing enrollment in family-focused preventive intervention research. Prev Sci (2000) 1.47
A prospective validation study of inclination, belief, and context predictors of family-focused prevention involvement. Fam Process (1997) 1.46
Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med (1981) 1.45
Endocrine treatment of breast cancer in women. Endocr Rev (1990) 1.44
Horse injuries and racing practices in National Hunt racehorses in the UK: the results of a prospective cohort study. Vet J (2004) 1.41
Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial. Ann Intern Med (1987) 1.39
Reducing adolescents' aggressive and hostile behaviors: randomized trial effects of a brief family intervention 4 years past baseline. Arch Pediatr Adolesc Med (2000) 1.37
Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients. J Natl Cancer Inst (1990) 1.34
A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer. Cancer (1977) 1.30
Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. J Clin Oncol (1986) 1.28
Histologic grading of breast cancer. Pathol Annu (1980) 1.28
Tubulolobular invasive breast cancer: a variant of lobular invasive cancer. Hum Pathol (1977) 1.28
Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. Semin Surg Oncol (1992) 1.27
Gene expression in human chondrocytes in late osteoarthritis is changed in both fibrillated and intact cartilage without evidence of generalised chondrocyte hypertrophy. Ann Rheum Dis (2010) 1.26
Alcohol initiation outcomes of universal family-focused preventive interventions: one- and two-year follow-ups of a controlled study. J Stud Alcohol Suppl (1999) 1.26
Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancer. Am J Clin Pathol (1980) 1.25
Assessing a public health approach to delay onset and progression of adolescent substance use: latent transition and log-linear analyses of longitudinal family preventive intervention outcomes. J Consult Clin Psychol (1999) 1.24
Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). I. Observations concerning the multicentricity of mammary cancer. Cancer (1975) 1.22
Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. J Clin Oncol (1985) 1.22
Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev (1994) 1.22
New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent. J Natl Cancer Inst (1991) 1.21
Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial. J Clin Oncol (1986) 1.17
Skeletal scintigraphy in the horse: current indications and validity as a diagnostic test. Vet J (2005) 1.17
A review of tendon injury: why is the equine superficial digital flexor tendon most at risk? Equine Vet J (2010) 1.16
Cultivation of human tenocytes in high-density culture. Histochem Cell Biol (2004) 1.12
Pathologic findings from the National Surgical Adjuvant Breast Project. VIII. Relationship of chemotherapeutic responsiveness to tumor differentiation. Cancer (1983) 1.10
Capacity for sliding between tendon fascicles decreases with ageing in injury prone equine tendons: a possible mechanism for age-related tendinopathy? Eur Cell Mater (2013) 1.07
Study of participation barriers in family-focused prevention: research issues and preliminary results. Int Q Community Health Educ (1992) 1.05
A cross-sectional study of geriatric horses in the United Kingdom. Part 1: Demographics and management practices. Equine Vet J (2010) 1.03
Pathologic findings from the national surgical adjuvant breast project. (Protocol no. 4). III. The significance of extranodal extension of axillary metastases. Am J Clin Pathol (1976) 1.02
Mesenchymal stem cell therapy in equine musculoskeletal disease: scientific fact or clinical fiction? Equine Vet J (2007) 1.02
Preparing for the drug free years: session-specific effects of a universal parent-training intervention with rural families. J Drug Educ (2001) 1.01
Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents. Cancer Treat Rep (1981) 1.01
Protective factors and young adolescent tendency to abstain from alcohol use: a model using two waves of intervention study data. Am J Community Psychol (1996) 0.99
Risk moderation of parent and child outcomes in a preventive intervention: a test and replication. Am J Orthopsychiatry (1998) 0.98
Validation of a client-based clinical metrology instrument for the evaluation of canine elbow osteoarthritis. J Small Anim Pract (2009) 0.96
Disease prevalence in geriatric horses in the United Kingdom: veterinary clinical assessment of 200 cases. Equine Vet J (2011) 0.96
Recent developments in the use of systemic adjuvant therapy for the treatment of breast cancer. Semin Oncol (1992) 0.96
Whip use and race progress are associated with horse falls in hurdle and steeplechase racing in the UK. Equine Vet J (2004) 0.94
Systemic adjuvant therapy in treatment of primary operable breast cancer: National Surgical Adjuvant Breast and Bowel Project experience. NCI Monogr (1986) 0.94
Comparison of owner-reported health problems with veterinary assessment of geriatric horses in the United Kingdom. Equine Vet J (2011) 0.93
Biofilms and their relevance to veterinary medicine. Vet Microbiol (2007) 0.93
Oxygen and pH-sensitivity of human osteoarthritic chondrocytes in 3-D alginate bead culture system. Osteoarthritis Cartilage (2013) 0.92
Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol no. 4). VI. Discriminants for five-year treatment failure. Cancer (1980) 0.92
Systemic therapy in node-negative patients: updated findings from NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst Monogr (1992) 0.91
The effect of D-penicillamine on pulmonary findings in systemic sclerosis. Arthritis Rheum (1985) 0.91
The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival. Cancer Treat Rep (1983) 0.90
Complete and partial hoof wall resection for keratoma removal: post operative complications and final outcome in 26 horses (1994-2004). Equine Vet J (2006) 0.90
The histopathology of mammographic patterns. Am J Clin Pathol (1978) 0.89
Post mortem evaluation of palmar osteochondral disease (traumatic osteochondrosis) of the metacarpo/metatarsophalangeal joint in Thoroughbred racehorses. Equine Vet J (2009) 0.88
Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings. Semin Surg Oncol (1992) 0.88
DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04. Cancer (1991) 0.88
Identifying program preferences through conjoint analysis: illustrative results from a parent sample. Am J Health Promot (1994) 0.88
Pathological findings from the national surgical adjuvant breast project (Protocol No. 4). IV. Significance of tumor necrosis. Hum Pathol (1978) 0.87
Systemic therapy in patients with node-negative breast cancer. A commentary based on two National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials. Ann Intern Med (1989) 0.86
Regulation of SOX9 in normal and osteoarthritic equine articular chondrocytes by hyperosmotic loading. Osteoarthritis Cartilage (2010) 0.86
Risk factors and sources of variation in horse falls in steeplechase racing in the UK. Prev Vet Med (2002) 0.86
Cartilage damage involving extrusion of mineralisable matrix from the articular calcified cartilage and subchondral bone. Eur Cell Mater (2011) 0.85